Endolymphatic hydrops – Diagnostics – Overview of Information and Clinical Research

Endolymphatic hydrops is a disorder affecting the fluid balance in your inner ear, where an abnormal buildup of fluid called endolymph can disrupt your hearing and balance. Understanding how this condition is diagnosed helps patients and doctors work together to manage symptoms and find the right path toward better quality of life.

Introduction: Who Should Seek Diagnostic Testing

If you are experiencing repeated episodes of dizziness, hearing problems, ringing in your ears, or a feeling of fullness or pressure in one or both ears, it may be time to seek a medical evaluation for endolymphatic hydrops. This condition does not always announce itself clearly, and symptoms can be confusing because they often come and go without warning. Some people notice that their hearing changes from day to day, especially for lower-pitched sounds, while others struggle with balance problems that make everyday activities difficult or unsafe.^[1]

You should consider diagnostic testing if you have experienced two or more episodes of spinning dizziness, also called vertigo, lasting anywhere from a few minutes to several hours or even a full day. These episodes may be accompanied by fluctuating hearing loss, meaning that your ability to hear may worsen during an attack and then improve afterward. If you also notice persistent tinnitus, which is a ringing, buzzing, or roaring sound in your ear, or if you feel constant pressure or fullness in one ear as though it is blocked, these are important signs that warrant a visit to a specialist.^[2]

People who have suffered head trauma, ear surgery, or who have underlying conditions such as allergies or autoimmune disorders should be particularly alert to these symptoms, as they may be at higher risk for developing secondary endolymphatic hydrops. In these cases, the fluid buildup occurs as a reaction to an injury or disease rather than appearing for no known reason.^[5]

Seeking a diagnosis early is important because untreated endolymphatic hydrops can lead to permanent hearing loss over time, typically after eight to ten years of recurring symptoms. Early intervention can help manage symptoms, preserve hearing, and reduce the frequency and severity of vertigo attacks. If your symptoms are severe enough to cause falls, interfere with your ability to work or drive, or lead to feelings of anxiety or depression, it is especially important to consult with a healthcare provider who understands inner ear disorders.^[7]

⚠️ Important

Not everyone with endolymphatic hydrops will develop Ménière’s disease, but people diagnosed with Ménière’s disease are thought to have endolymphatic hydrops. If your doctor tells you that the cause of your vertigo is known, then by definition it is not Ménière’s disease but may still be endolymphatic hydrops secondary to another condition.

Classic Diagnostic Methods

Diagnosing endolymphatic hydrops typically begins with a thorough clinical evaluation by an ear, nose, and throat specialist, also called an otolaryngologist or ENT consultant. The diagnosis is often clinical, which means it is based on your medical history, the pattern of your symptoms, and the results of specific tests rather than on a single definitive test. This approach is necessary because the fluid buildup happens deep within the inner ear, in structures that are difficult to observe directly without advanced imaging.^[1]

Your doctor will start by asking detailed questions about your symptoms. They will want to know how long your episodes of dizziness last, whether you have experienced hearing loss, and if the hearing loss fluctuates or stays constant. They will also ask about tinnitus, the sensation of ear fullness, and any other symptoms such as nausea or vomiting. Understanding the timing and pattern of these symptoms is critical, as endolymphatic hydrops often presents with episodes that come and go, separated by periods when you feel relatively normal.^[4]

One of the key tests used to assess hearing is called audiometry. This is a hearing test that measures how well you can hear sounds at different pitches and volumes. In people with endolymphatic hydrops, audiometry often shows a specific pattern of hearing loss, particularly affecting low-frequency sounds. In some cases, hearing may be typical in the middle range but poor at both low and high frequencies. Audiometry is non-invasive and helps your doctor understand the extent and pattern of hearing damage, which can support the diagnosis.^[12]

Another important diagnostic tool is electrocochleography, often abbreviated as ECoG. This test measures the electrical response of the inner ear, specifically the eighth cranial nerve, when sounds such as clicks or tones are presented to your ear. In people with endolymphatic hydrops, the test may show certain abnormalities in how the nerve responds to sound. These findings can strengthen a clinical diagnosis, although they are not definitive on their own.^[5]

Balance testing is also commonly performed. Tests such as electronystagmography (ENG) or videonystagmography (VNG) measure balance by studying the movement of your eyes. Your eyes naturally move in response to changes in balance, and these tests can detect abnormal patterns that suggest inner ear problems. During these tests, your doctor may have you follow a moving target with your eyes, place your head in different positions, or use temperature changes to trigger a reaction from your inner ear. This last part, called the caloric test, involves introducing warm or cold air or water into the ear canal to see how your balance system responds.^[12]

Rotary-chair testing is another method used to assess balance. In this test, you sit in a computer-controlled chair that rotates slowly from side to side while your eye movements are monitored. This test measures how well your inner ear works based on the relationship between head movement and eye movement. It can help distinguish between different types of balance disorders.^[12]

In recent years, advanced imaging techniques have become available that allow doctors to visualize endolymphatic hydrops directly. One such method is delayed intravenous contrast-enhanced magnetic resonance imaging, or delayed contrast MRI. In this test, a contrast agent is injected into a vein, and after a waiting period, an MRI scan is performed. The contrast highlights the inner ear structures, and doctors can see whether the endolymphatic space is enlarged. This test can provide a definitive diagnosis of endolymphatic hydrops, though it is not always used because clinical diagnosis is often accurate and this imaging is more expensive and not widely available.^[5]^[11]

Your doctor may also order blood tests or other laboratory studies to rule out underlying conditions that could be causing secondary endolymphatic hydrops. For example, testing for thyroid problems, autoimmune diseases, or metabolic imbalances can help identify whether your symptoms are related to another treatable condition. If secondary hydrops is suspected, treating the underlying cause becomes the first priority.^[4]

It is important to understand that diagnosing endolymphatic hydrops can take time. Because symptoms fluctuate and the condition can mimic other disorders, your doctor may need to see you multiple times, track your symptoms over weeks or months, and repeat some tests to confirm the diagnosis. This process can be frustrating, but it ensures that you receive the correct diagnosis and appropriate treatment.^[5]

Diagnostics for Clinical Trial Qualification

When clinical trials are designed to test new treatments for endolymphatic hydrops or related conditions such as Ménière’s disease, specific diagnostic criteria are used to ensure that all participants truly have the condition being studied. These criteria are usually more rigorous than those used in everyday clinical practice, because researchers need to be certain that any changes observed during the trial are due to the treatment being tested and not due to differences in diagnosis among participants.^[4]

To qualify for a clinical trial, a patient typically needs to meet standardized diagnostic criteria. For Ménière’s disease, which is a form of primary endolymphatic hydrops, the American Academy of Otolaryngology-Head and Neck Surgery established clear criteria in 1995. According to these criteria, a diagnosis requires at least two episodes of vertigo, each lasting between 20 minutes and 12 hours or up to 24 hours, along with hearing loss confirmed by a hearing test. The patient must also experience tinnitus or a feeling of fullness or pressure in the ear. These criteria help ensure that researchers are studying a consistent group of patients.^[12]

Clinical trials may require participants to undergo detailed audiometry at the time of enrollment and at regular intervals throughout the study. This allows researchers to objectively measure any changes in hearing over time and to assess whether the treatment being studied has any impact on hearing loss. Audiometry results are particularly important in trials because fluctuating hearing loss is a hallmark of endolymphatic hydrops, and improvements in hearing could indicate that a treatment is working.^[12]

Electrocochleography may also be required as part of trial enrollment. This test provides objective data about the electrical activity in the inner ear and can help confirm the presence of hydrops. Some trials may use ECoG results to stratify patients into different groups based on the severity of their condition, allowing researchers to see whether a treatment works better for some patients than others.^[5]

Advanced imaging, such as delayed contrast-enhanced MRI, is increasingly being used in clinical trials to visualize endolymphatic hydrops directly. This imaging can provide definitive evidence of fluid buildup in the inner ear and can be used to measure whether a treatment reduces the degree of hydrops over time. Some studies have shown that hydrops visible on MRI can change in response to treatment, such as the medication acetazolamide, which is a type of diuretic. This kind of objective measurement is valuable in clinical trials because it allows researchers to see physical changes in the inner ear rather than relying solely on patients’ reports of symptoms.^[11]

Clinical trials may also include balance testing, such as electronystagmography or rotary-chair testing, to objectively measure balance function at the start of the trial and after treatment. These tests help researchers understand whether a treatment improves balance and reduces the frequency or severity of vertigo attacks.^[12]

In addition to these diagnostic tests, clinical trials often require detailed symptom diaries. Participants may be asked to record the frequency, duration, and severity of their vertigo episodes, as well as any changes in hearing, tinnitus, or ear fullness. This information helps researchers track how symptoms change over time and whether a treatment provides meaningful relief.^[4]

Blood tests and other laboratory studies may also be part of the screening process for clinical trials, especially if the trial is studying treatments for secondary endolymphatic hydrops. Researchers need to confirm that participants have or do not have certain underlying conditions, depending on the focus of the study. For example, a trial studying the role of autoimmune processes in hydrops might require participants to have positive tests for specific autoimmune markers, while a trial focused on dietary interventions might exclude people with uncontrolled diabetes or kidney disease.^[5]

⚠️ Important

If you are interested in participating in a clinical trial for endolymphatic hydrops or Ménière’s disease, be prepared for a thorough diagnostic workup. Trials often require multiple visits, repeated testing, and careful documentation of your symptoms. While this can be time-consuming, your participation can contribute to the development of better treatments for this condition.

Prognosis and Survival Rate

Prognosis

The prognosis for people with endolymphatic hydrops varies depending on the underlying cause, the severity of symptoms, and how well the condition responds to treatment. For many people, symptoms can be managed effectively with lifestyle changes, medications, and other treatments, allowing them to maintain a good quality of life. However, endolymphatic hydrops is typically a chronic condition, meaning it lasts for years and may require ongoing management.^[1]

One of the most significant long-term concerns is progressive hearing loss. Over time, usually after eight to ten years of recurring symptoms, many people with endolymphatic hydrops experience permanent hearing loss in the affected ear. This hearing loss tends to worsen gradually, and while some fluctuation may continue, the overall trend is toward decreased hearing ability. Early diagnosis and treatment can help slow this progression, but complete prevention of hearing loss is not always possible.^[7]

Vertigo attacks may also change over time. In the early stages of the condition, vertigo episodes may be frequent and severe, causing significant disruption to daily life. As the condition progresses, some people experience fewer vertigo attacks, but this may come at the cost of worsening hearing and balance problems. The inner ear structures can become damaged over time, leading to ongoing balance issues even when acute vertigo episodes become less frequent.^[7]

The prognosis for secondary endolymphatic hydrops depends heavily on whether the underlying cause can be identified and treated. For example, if hydrops is caused by an autoimmune disorder and that disorder is effectively managed, symptoms may improve significantly. Similarly, if hydrops is related to head trauma or ear surgery, symptoms may stabilize once healing is complete, although some permanent changes may remain.^[5]

Mental health can also be affected by endolymphatic hydrops. The unpredictability of vertigo attacks, the frustration of fluctuating hearing loss, and the constant presence of tinnitus can lead to anxiety and depression. People may worry about when the next attack will occur and whether they will be able to continue working, driving, or participating in activities they enjoy. Addressing these mental health concerns is an important part of overall disease management.^[7]

Survival Rate

Endolymphatic hydrops is not a life-threatening condition, and it does not directly affect survival rates. People with this condition have a normal life expectancy. However, the condition can significantly impact quality of life, and severe vertigo attacks can lead to dangerous falls or accidents, particularly if they occur while a person is driving, climbing stairs, or operating machinery. Taking precautions during episodes and working with a healthcare provider to manage symptoms can help reduce these risks.^[7]

While endolymphatic hydrops itself does not shorten life, the underlying conditions that can cause secondary hydrops may have their own effects on health and longevity. For example, autoimmune diseases, diabetes, and cardiovascular conditions can all contribute to secondary hydrops, and managing these conditions is important for overall health. By addressing both the hydrops and any underlying health issues, people can maintain better long-term health outcomes.^[5]

#1 Clinical Trials Search in Europe